Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 VPR-66
1.2.3 INV-17
1.2.4 GSK-2981278
1.2.5 BBI-6000
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nuclear Receptor ROR-Gamma Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Nuclear Receptor ROR-Gamma Market Size (2018-2034)
2.2 Nuclear Receptor ROR-Gamma Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Nuclear Receptor ROR-Gamma Market Size by Region (2018-2023)
2.4 Global Nuclear Receptor ROR-Gamma Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Nuclear Receptor ROR-Gamma Countries Ranking by Market Size
3 Nuclear Receptor ROR-Gamma Competitive by Company
3.1 Global Nuclear Receptor ROR-Gamma Revenue by Players
3.1.1 Global Nuclear Receptor ROR-Gamma Revenue by Players (2018-2023)
3.1.2 Global Nuclear Receptor ROR-Gamma Market Share by Players (2018-2023)
3.2 Global Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Nuclear Receptor ROR-Gamma Revenue
3.4 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio
3.4.1 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Receptor ROR-Gamma Revenue in 2024
3.5 Global Key Players of Nuclear Receptor ROR-Gamma Head office and Area Served
3.6 Global Key Players of Nuclear Receptor ROR-Gamma, Product and Application
3.7 Global Key Players of Nuclear Receptor ROR-Gamma, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Nuclear Receptor ROR-Gamma Breakdown Data by Type
4.1 Global Nuclear Receptor ROR-Gamma Historic Revenue by Type (2018-2023)
4.2 Global Nuclear Receptor ROR-Gamma Forecasted Revenue by Type (2024-2034)
5 Global Nuclear Receptor ROR-Gamma Breakdown Data by Application
5.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Application (2018-2023)
5.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023)
6.2 North America Nuclear Receptor ROR-Gamma Revenue by Type (2018-2034)
6.3 North America Nuclear Receptor ROR-Gamma Revenue by Application (2018-2034)
6.4 North America Nuclear Receptor ROR-Gamma Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023)
7.2 Europe Nuclear Receptor ROR-Gamma Revenue by Type (2018-2034)
7.3 Europe Nuclear Receptor ROR-Gamma Revenue by Application (2018-2034)
7.4 Europe Nuclear Receptor ROR-Gamma Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023)
8.2 Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Type (2018-2034)
8.3 Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Application (2018-2034)
8.4 Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023)
9.2 Latin America Nuclear Receptor ROR-Gamma Revenue by Type (2018-2034)
9.3 Latin America Nuclear Receptor ROR-Gamma Revenue by Application (2018-2034)
9.4 Latin America Nuclear Receptor ROR-Gamma Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023)
10.2 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Type (2018-2034)
10.3 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Application (2018-2034)
10.4 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 4SC AG
11.1.1 4SC AG Company Details
11.1.2 4SC AG Business Overview
11.1.3 4SC AG Nuclear Receptor ROR-Gamma Products and Services
11.1.4 4SC AG Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.1.5 4SC AG Nuclear Receptor ROR-Gamma SWOT Analysis
11.1.6 4SC AG Recent Development
11.2 Advinus Therapeutics Ltd.
11.2.1 Advinus Therapeutics Ltd. Company Details
11.2.2 Advinus Therapeutics Ltd. Business Overview
11.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Products and Services
11.2.4 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.2.5 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma SWOT Analysis
11.2.6 Advinus Therapeutics Ltd. Recent Development
11.3 Arrien Pharmaceuticals, LLC
11.3.1 Arrien Pharmaceuticals, LLC Company Details
11.3.2 Arrien Pharmaceuticals, LLC Business Overview
11.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Products and Services
11.3.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.3.5 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma SWOT Analysis
11.3.6 Arrien Pharmaceuticals, LLC Recent Development
11.4 Aurigene Discovery Technologies Limited
11.4.1 Aurigene Discovery Technologies Limited Company Details
11.4.2 Aurigene Discovery Technologies Limited Business Overview
11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Products and Services
11.4.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.4.5 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma SWOT Analysis
11.4.6 Aurigene Discovery Technologies Limited Recent Development
11.5 Biogen, Inc.
11.5.1 Biogen, Inc. Company Details
11.5.2 Biogen, Inc. Business Overview
11.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Products and Services
11.5.4 Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.5.5 Biogen, Inc. Nuclear Receptor ROR-Gamma SWOT Analysis
11.5.6 Biogen, Inc. Recent Development
11.6 Brickell Biotech, Inc.
11.6.1 Brickell Biotech, Inc. Company Details
11.6.2 Brickell Biotech, Inc. Business Overview
11.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Products and Services
11.6.4 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.6.5 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma SWOT Analysis
11.6.6 Brickell Biotech, Inc. Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Products and Services
11.7.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.7.5 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma SWOT Analysis
11.7.6 Bristol-Myers Squibb Company Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Details
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Products and Services
11.8.4 Celgene Corporation Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.8.5 Celgene Corporation Nuclear Receptor ROR-Gamma SWOT Analysis
11.8.6 Celgene Corporation Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Details
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Products and Services
11.9.4 Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.9.5 Genentech, Inc. Nuclear Receptor ROR-Gamma SWOT Analysis
11.9.6 Genentech, Inc. Recent Development
11.10 Genfit SA
11.10.1 Genfit SA Company Details
11.10.2 Genfit SA Business Overview
11.10.3 Genfit SA Nuclear Receptor ROR-Gamma Products and Services
11.10.4 Genfit SA Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.10.5 Genfit SA Nuclear Receptor ROR-Gamma SWOT Analysis
11.10.6 Genfit SA Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Details
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Products and Services
11.11.4 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.11.5 GlaxoSmithKline Plc Recent Development
11.12 Hanmi Pharmaceuticals, Co. Ltd.
11.12.1 Hanmi Pharmaceuticals, Co. Ltd. Company Details
11.12.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
11.12.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Products and Services
11.12.4 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.12.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
11.13 Karo Bio AB
11.13.1 Karo Bio AB Company Details
11.13.2 Karo Bio AB Business Overview
11.13.3 Karo Bio AB Nuclear Receptor ROR-Gamma Products and Services
11.13.4 Karo Bio AB Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.13.5 Karo Bio AB Recent Development
11.14 Lead Pharma Holding B.V.
11.14.1 Lead Pharma Holding B.V. Company Details
11.14.2 Lead Pharma Holding B.V. Business Overview
11.14.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Products and Services
11.14.4 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.14.5 Lead Pharma Holding B.V. Recent Development
11.15 Nuevolution AB
11.15.1 Nuevolution AB Company Details
11.15.2 Nuevolution AB Business Overview
11.15.3 Nuevolution AB Nuclear Receptor ROR-Gamma Products and Services
11.15.4 Nuevolution AB Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.15.5 Nuevolution AB Recent Development
11.16 Phenex Pharmaceuticals AG
11.16.1 Phenex Pharmaceuticals AG Company Details
11.16.2 Phenex Pharmaceuticals AG Business Overview
11.16.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Products and Services
11.16.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.16.5 Phenex Pharmaceuticals AG Recent Development
11.17 Reata Pharmaceuticals, Inc.
11.17.1 Reata Pharmaceuticals, Inc. Company Details
11.17.2 Reata Pharmaceuticals, Inc. Business Overview
11.17.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Products and Services
11.17.4 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.17.5 Reata Pharmaceuticals, Inc. Recent Development
11.18 Teijin Pharma Limited
11.18.1 Teijin Pharma Limited Company Details
11.18.2 Teijin Pharma Limited Business Overview
11.18.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Products and Services
11.18.4 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.18.5 Teijin Pharma Limited Recent Development
11.19 Visionary Pharmaceuticals, Inc.
11.19.1 Visionary Pharmaceuticals, Inc. Company Details
11.19.2 Visionary Pharmaceuticals, Inc. Business Overview
11.19.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Products and Services
11.19.4 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.19.5 Visionary Pharmaceuticals, Inc. Recent Development
11.20 Vitae Pharmaceuticals, Inc.
11.20.1 Vitae Pharmaceuticals, Inc. Company Details
11.20.2 Vitae Pharmaceuticals, Inc. Business Overview
11.20.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Products and Services
11.20.4 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023)
11.20.5 Vitae Pharmaceuticals, Inc. Recent Development
12 Nuclear Receptor ROR-Gamma Market Dynamics
12.1 Nuclear Receptor ROR-Gamma Industry Trends
12.2 Nuclear Receptor ROR-Gamma Market Drivers
12.3 Nuclear Receptor ROR-Gamma Market Challenges
12.4 Nuclear Receptor ROR-Gamma Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of VPR-66
Table 3. Key Players of INV-17
Table 4. Key Players of GSK-2981278
Table 5. Key Players of BBI-6000
Table 6. Key Players of Others
Table 7. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 8. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 9. Global Nuclear Receptor ROR-Gamma Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Nuclear Receptor ROR-Gamma Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 11. Global Nuclear Receptor ROR-Gamma Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 12. Global Nuclear Receptor ROR-Gamma Revenue by Players (2018-2023) & (US$ Million)
Table 13. Global Nuclear Receptor ROR-Gamma Market Share by Players (2018-2023)
Table 14. Global Top Nuclear Receptor ROR-Gamma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2024)
Table 15. Ranking of Global Top Nuclear Receptor ROR-Gamma Companies by Revenue (US$ Million) in 2024
Table 16. Global 5 Largest Players Market Share by Nuclear Receptor ROR-Gamma Revenue (CR5 and HHI) & (2018-2023)
Table 17. Global Key Players of Nuclear Receptor ROR-Gamma, Headquarters and Area Served
Table 18. Global Key Players of Nuclear Receptor ROR-Gamma, Product and Application
Table 19. Global Key Players of Nuclear Receptor ROR-Gamma, Date of Enter into This Industry
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Nuclear Receptor ROR-Gamma Market Size by Type (2018-2023) & (US$ Million)
Table 22. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2018-2023)
Table 23. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 24. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2024-2034)
Table 25. Global Nuclear Receptor ROR-Gamma Market Size by Application (2018-2023) & (US$ Million)
Table 26. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2018-2023)
Table 27. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 28. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2024-2034)
Table 29. North America Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023) & (US$ Million)
Table 30. North America Nuclear Receptor ROR-Gamma Revenue by Type (2018-2023) & (US$ Million)
Table 31. North America Nuclear Receptor ROR-Gamma Revenue by Type (2024-2034) & (US$ Million)
Table 32. North America Nuclear Receptor ROR-Gamma Revenue by Application (2018-2023) & (US$ Million)
Table 33. North America Nuclear Receptor ROR-Gamma Revenue by Application (2024-2034) & (US$ Million)
Table 34. North America Nuclear Receptor ROR-Gamma Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. North America Nuclear Receptor ROR-Gamma Revenue by Country (2018-2023) & (US$ Million)
Table 36. North America Nuclear Receptor ROR-Gamma Revenue by Country (2024-2034) & (US$ Million)
Table 37. Europe Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023) & (US$ Million)
Table 38. Europe Nuclear Receptor ROR-Gamma Revenue by Type (2018-2023) & (US$ Million)
Table 39. Europe Nuclear Receptor ROR-Gamma Revenue by Type (2024-2034) & (US$ Million)
Table 40. Europe Nuclear Receptor ROR-Gamma Revenue by Application (2018-2023) & (US$ Million)
Table 41. Europe Nuclear Receptor ROR-Gamma Revenue by Application (2024-2034) & (US$ Million)
Table 42. Europe Nuclear Receptor ROR-Gamma Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Europe Nuclear Receptor ROR-Gamma Revenue by Country (2018-2023) & (US$ Million)
Table 44. Europe Nuclear Receptor ROR-Gamma Revenue by Country (2024-2034) & (US$ Million)
Table 45. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023) & (US$ Million)
Table 46. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Type (2018-2023) & (US$ Million)
Table 47. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Type (2024-2034) & (US$ Million)
Table 48. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Application (2018-2023) & (US$ Million)
Table 49. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Application (2024-2034) & (US$ Million)
Table 50. Asia-Pacific Nuclear Receptor ROR-Gamma Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 51. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Region (2018-2023) & (US$ Million)
Table 52. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Region (2024-2034) & (US$ Million)
Table 53. Latin America Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023) & (US$ Million)
Table 54. Latin America Nuclear Receptor ROR-Gamma Revenue by Type (2018-2023) & (US$ Million)
Table 55. Latin America Nuclear Receptor ROR-Gamma Revenue by Type (2024-2034) & (US$ Million)
Table 56. Latin America Nuclear Receptor ROR-Gamma Revenue by Application (2018-2023) & (US$ Million)
Table 57. Latin America Nuclear Receptor ROR-Gamma Revenue by Application (2024-2034) & (US$ Million)
Table 58. Latin America Nuclear Receptor ROR-Gamma Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 59. Latin America Nuclear Receptor ROR-Gamma Revenue by Country (2018-2023) & (US$ Million)
Table 60. Latin America Nuclear Receptor ROR-Gamma Revenue by Country (2024-2034) & (US$ Million)
Table 61. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Company (2021-2023) & (US$ Million)
Table 62. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Type (2018-2023) & (US$ Million)
Table 63. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Type (2024-2034) & (US$ Million)
Table 64. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Application (2024-2034) & (US$ Million)
Table 66. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 67. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Country (2018-2023) & (US$ Million)
Table 68. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Country (2024-2034) & (US$ Million)
Table 69. 4SC AG Company Details
Table 70. 4SC AG Business Overview
Table 71. 4SC AG Nuclear Receptor ROR-Gamma Product and Services
Table 72. 4SC AG Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 73. 4SC AG Nuclear Receptor ROR-Gamma SWOT Analysis
Table 74. 4SC AG Recent Development
Table 75. Advinus Therapeutics Ltd. Company Details
Table 76. Advinus Therapeutics Ltd. Business Overview
Table 77. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product and Services
Table 78. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 79. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma SWOT Analysis
Table 80. Advinus Therapeutics Ltd. Recent Development
Table 81. Arrien Pharmaceuticals, LLC Company Details
Table 82. Arrien Pharmaceuticals, LLC Business Overview
Table 83. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product and Services
Table 84. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 85. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma SWOT Analysis
Table 86. Arrien Pharmaceuticals, LLC Recent Development
Table 87. Aurigene Discovery Technologies Limited Company Details
Table 88. Aurigene Discovery Technologies Limited Business Overview
Table 89. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product and Services
Table 90. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 91. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma SWOT Analysis
Table 92. Aurigene Discovery Technologies Limited Recent Development
Table 93. Biogen, Inc. Company Details
Table 94. Biogen, Inc. Business Overview
Table 95. Biogen, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 96. Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 97. Biogen, Inc. Nuclear Receptor ROR-Gamma SWOT Analysis
Table 98. Biogen, Inc. Recent Development
Table 99. Brickell Biotech, Inc. Company Details
Table 100. Brickell Biotech, Inc. Business Overview
Table 101. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 102. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 103. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma SWOT Analysis
Table 104. Brickell Biotech, Inc. Recent Development
Table 105. Bristol-Myers Squibb Company Company Details
Table 106. Bristol-Myers Squibb Company Business Overview
Table 107. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product and Services
Table 108. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 109. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma SWOT Analysis
Table 110. Bristol-Myers Squibb Company Recent Development
Table 111. Celgene Corporation Company Details
Table 112. Celgene Corporation Business Overview
Table 113. Celgene Corporation Nuclear Receptor ROR-Gamma Product and Services
Table 114. Celgene Corporation Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 115. Celgene Corporation Nuclear Receptor ROR-Gamma SWOT Analysis
Table 116. Celgene Corporation Recent Development
Table 117. Genentech, Inc. Company Details
Table 118. Genentech, Inc. Business Overview
Table 119. Genentech, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 120. Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 121. Genentech, Inc. Nuclear Receptor ROR-Gamma SWOT Analysis
Table 122. Genentech, Inc. Recent Development
Table 123. Genfit SA Company Details
Table 124. Genfit SA Business Overview
Table 125. Genfit SA Nuclear Receptor ROR-Gamma Product and Services
Table 126. Genfit SA Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 127. Genfit SA Nuclear Receptor ROR-Gamma SWOT Analysis
Table 128. Genfit SA Recent Development
Table 129. GlaxoSmithKline Plc Company Details
Table 130. GlaxoSmithKline Plc Business Overview
Table 131. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product and Services
Table 132. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 133. GlaxoSmithKline Plc Recent Development
Table 134. Hanmi Pharmaceuticals, Co. Ltd. Company Details
Table 135. Hanmi Pharmaceuticals, Co. Ltd. Business Overview
Table 136. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product and Services
Table 137. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 138. Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table 139. Karo Bio AB Company Details
Table 140. Karo Bio AB Business Overview
Table 141. Karo Bio AB Nuclear Receptor ROR-Gamma Product and Services
Table 142. Karo Bio AB Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 143. Karo Bio AB Recent Development
Table 144. Lead Pharma Holding B.V. Company Details
Table 145. Lead Pharma Holding B.V. Business Overview
Table 146. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product and Services
Table 147. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 148. Lead Pharma Holding B.V. Recent Development
Table 149. Nuevolution AB Company Details
Table 150. Nuevolution AB Business Overview
Table 151. Nuevolution AB Nuclear Receptor ROR-Gamma Product and Services
Table 152. Nuevolution AB Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 153. Nuevolution AB Recent Development
Table 154. Phenex Pharmaceuticals AG Company Details
Table 155. Phenex Pharmaceuticals AG Business Overview
Table 156. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product and Services
Table 157. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 158. Phenex Pharmaceuticals AG Recent Development
Table 159. Reata Pharmaceuticals, Inc. Company Details
Table 160. Reata Pharmaceuticals, Inc. Business Overview
Table 161. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 162. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 163. Reata Pharmaceuticals, Inc. Recent Development
Table 164. Teijin Pharma Limited Company Details
Table 165. Teijin Pharma Limited Business Overview
Table 166. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product and Services
Table 167. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 168. Teijin Pharma Limited Recent Development
Table 169. Visionary Pharmaceuticals, Inc. Company Details
Table 170. Visionary Pharmaceuticals, Inc. Business Overview
Table 171. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 172. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 173. Visionary Pharmaceuticals, Inc. Recent Development
Table 174. Vitae Pharmaceuticals, Inc. Company Details
Table 175. Vitae Pharmaceuticals, Inc. Business Overview
Table 176. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 177. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue in Nuclear Receptor ROR-Gamma Business (2018-2023) & (US$ Million)
Table 178. Vitae Pharmaceuticals, Inc. Recent Development
Table 179. Nuclear Receptor ROR-Gamma Market Trends
Table 180. Nuclear Receptor ROR-Gamma Market Drivers
Table 181. Nuclear Receptor ROR-Gamma Market Challenges
Table 182. Nuclear Receptor ROR-Gamma Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Receptor ROR-Gamma Product Picture
Figure 2. Global Nuclear Receptor ROR-Gamma Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Nuclear Receptor ROR-Gamma Market Share by Type: 2024 VS 2034
Figure 4. VPR-66 Features
Figure 5. INV-17 Features
Figure 6. GSK-2981278 Features
Figure 7. BBI-6000 Features
Figure 8. Others Features
Figure 9. Global Nuclear Receptor ROR-Gamma Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 10. Global Nuclear Receptor ROR-Gamma Market Share by Application: 2024 VS 2034
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Nuclear Receptor ROR-Gamma Report Years Considered
Figure 15. Global Nuclear Receptor ROR-Gamma Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Nuclear Receptor ROR-Gamma Market Size 2018-2034 (US$ Million)
Figure 17. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Region: 2024 VS 2034
Figure 18. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Region in 2018 VS 2024
Figure 19. Global Nuclear Receptor ROR-Gamma Revenue Market Share Forecast by Region (2024-2034)
Figure 20. Global Top 10 Nuclear Receptor ROR-Gamma Countries Ranking by Market Size (US$ Million) in 2024
Figure 21. Global Nuclear Receptor ROR-Gamma Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 22. Global Nuclear Receptor ROR-Gamma Market Share by Players in 2024
Figure 23. Global Top Nuclear Receptor ROR-Gamma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Nuclear Receptor ROR-Gamma Revenue in 2024
Figure 25. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Company in 2024
Figure 26. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2018-2034)
Figure 27. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2018-2034)
Figure 28. North America Nuclear Receptor ROR-Gamma Revenue Share by Country (2018-2034)
Figure 29. U.S. Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 30. Canada Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 31. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Company in 2024
Figure 32. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2018-2034)
Figure 33. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2018-2034)
Figure 34. Europe Nuclear Receptor ROR-Gamma Revenue Share by Country (2018-2034)
Figure 35. Germany Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 36. France Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 37. U.K. Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 38. Italy Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 39. Russia Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 40. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Company in 2024
Figure 41. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2018-2034)
Figure 42. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2018-2034)
Figure 43. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Share by Region (2018-2034)
Figure 44. China Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 45. Japan Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 46. South Korea Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 47. India Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 48. Australia Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 49. Taiwan Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 50. Indonesia Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 51. Thailand Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 52. Malaysia Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 53. Philippines Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 54. Vietnam Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 55. Latin America Nuclear Receptor ROR-Gamma Revenue Market Share by Company in 2024
Figure 56. Latin America Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2018-2034)
Figure 57. Latin America Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2018-2034)
Figure 58. Latin America Nuclear Receptor ROR-Gamma Revenue Share by Country (2018-2034)
Figure 59. Mexico Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 60. Brazil Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 61. Argentina Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 62. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Company in 2024
Figure 63. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2018-2034)
Figure 64. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2018-2034)
Figure 65. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Share by Country (2018-2034)
Figure 66. Turkey Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 67. Saudi Arabia Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 68. UAE Nuclear Receptor ROR-Gamma Revenue (2018-2034) & (US$ Million)
Figure 69. 4SC AG Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 70. Advinus Therapeutics Ltd. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 71. Arrien Pharmaceuticals, LLC Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 72. Aurigene Discovery Technologies Limited Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 73. Biogen, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 74. Brickell Biotech, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 75. Bristol-Myers Squibb Company Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 76. Celgene Corporation Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 77. Genentech, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 78. Genfit SA Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 79. GlaxoSmithKline Plc Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 80. Hanmi Pharmaceuticals, Co. Ltd. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 81. Karo Bio AB Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 82. Lead Pharma Holding B.V. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 83. Nuevolution AB Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 84. Phenex Pharmaceuticals AG Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 85. Reata Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 86. Teijin Pharma Limited Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 87. Visionary Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 88. Vitae Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2018-2023)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed